No definition available.
Non-seminoma of testis, excluding all cancers (controls excluding all cancers)
C3_TESTIS_NONSEMINOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
225 |
4. Check minimum number of eventsNone |
225 |
5. Include endpointsNone |
225 |
6. Filter based on genotype QC (FinnGen only) |
225 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-seminoma of testis, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Non-seminoma of testis
- Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 225 | - | 225 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 30.78 | - | 30.78 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 203
- Matched controls
- 2029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
194.4
154
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
1348.5
192.0
158
5
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
796.1
143.3
125
*
130
Kela drug reimbursment
Malignant tumour
+∞
114.8
99
*
A03FA01
ATC
metoclopramide; systemic, rectal
29.3
67.6
95
59
JN4BD
NOMESCO Finland
Extensive body CT
41.2
66.7
84
34
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
65.2
59
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
57.0
52
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
50.1
46
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
46.7
43
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
45.6
42
*
L03AA02
ATC
filgrastim; parenteral
505.2
42.8
41
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
17.4
37.9
62
50
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
37.7
35
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
+∞
36.6
34
*
A04AA02
ATC
granisetron; systemic, transdermal
415.0
36.2
35
*
JN4AD
NOMESCO Finland
Body CT examination
61.8
35.0
40
8
H02AB02
ATC
dexamethasone; systemic
68.4
34.7
39
7
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
32.1
30
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
31.0
29
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
31.0
29
*
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
29.9
28
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.8
29.6
118
393
A04AA01
ATC
ondansetron; systemic, rectal
45.3
25.7
31
8
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
25.6
24
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
25.6
24
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
25.6
24
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
24.5
23
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
23.4
22
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
7.1
20.8
55
101
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
20.1
19
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
51.6
19.6
23
5
DFF00
NOMESCO Finland
Pure tone audiometry
9.7
18.3
38
47
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
18.0
17
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.9
16
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
16.9
16
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
16.9
16
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
16.6
15.8
25
17
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
15.8
15
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
15.8
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.1
15.6
73
247
JN3AD
NOMESCO Finland
Abdominal CT examination
8.7
15.2
33
44
B01AB05
ATC
enoxaparin; parenteral
4.7
14.8
56
153
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
14.8
14
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
161.1
14.7
15
*
N02BE01
ATC
paracetamol; systemic, rectal
3.9
13.8
171
1174
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
9.7
13.8
28
33
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
149.6
13.6
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
13.1
81
333
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
12.6
12
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
12.6
12
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.9
12.1
21
18
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.9
11.9
34
67
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
11.6
11
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
11.6
11
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
11.6
11
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.0
11.2
31
59
B01AB10
ATC
tinzaparin; parenteral
11.5
11.1
20
19
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
10.5
10
*
WW500
NOMESCO Finland
Blood transfusion
20.1
10.4
15
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.0
10.3
23
32
WX402
NOMESCO Finland
General anaesthesia
3.9
10.1
44
135
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
9.9
40
114
N02AA05
ATC
oxycodone; systemic
5.5
9.6
28
57
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.4
9
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
9.4
9
*
WZC30
NOMESCO Finland
Teaching
4.1
8.5
33
91
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
8.4
8
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
15.3
8.3
13
9
Y05
ICPC
Scrotum/testis sympt/compl other
10.0
7.9
15
16
N05BA06
ATC
lorazepam; systemic, sublingual
6.6
7.8
19
31
ZX120
NOMESCO Finland
Intravenous
5.0
7.7
24
53
R50.9
ICD-10 Finland
Fever, unspecified
3.5
7.7
36
117
M04AA01
ATC
allopurinol; systemic
4.4
7.4
26
65
Y78
ICPC
Malign neopl male genital other
+∞
7.3
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
7.3
7
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
7.3
7
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
16.5
7.3
11
7
JN4CD
NOMESCO Finland
Very extensive body CT
20.9
7.2
10
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
7.1
25
63
WX320
NOMESCO Finland
Spinalanesthesy
3.0
6.9
40
152
N02AX02
ATC
tramadol; systemic, rectal
2.3
6.7
78
435
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.8
6.7
11
9
A02BC02
ATC
pantoprazole; systemic
2.1
6.5
107
697
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
6.4
33
116
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
+∞
6.3
6
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
6.3
6
*
E29.1
ICD-10 Finland
Testicular hypofunction
7.1
6.2
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
72
35
29.78
99.36
3.4
1.5
18.3
8.4
iu/l
2.14
55
27
80
5
246.32
82.35
12.1
1.0
—
—
—
0
0
86
86
15.57
81.51
3.2
1.6
8.7
4.2
u/l
3.73
70
79
34
43
9.14
25.86
1.4
3.1
177.3
174.5
%
0.04
34
43
97
338
4.29
24.89
6.1
1.9
2.4
2.4
mmol/l
0.39
89
304
31
40
8.83
23.13
1.3
3.6
3.5
3.9
g/l
0.41
31
40
126
556
3.88
22.54
9.9
6.7
1.2
1.2
mmol/l
0.25
102
487
115
488
3.77
21.61
4.7
3.6
—
—
—
0
0
74
249
3.94
19.29
2.4
2.4
—
—
—
0
0
159
875
3.79
19.22
14.2
8.5
3.4
4.1
e9/l
5.43
145
768
114
535
3.29
17.34
11.4
4.1
36.9
37.4
g/l
0.38
107
505
84
329
3.48
17.17
3.0
2.6
0.6
0.3
e6/l
0.42
64
238
99
438
3.25
16.45
3.3
2.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
25
8.68
15.13
3.9
2.3
0.3
0.3
u/ml
0.13
12
14
24
38
6.95
14.88
2.6
1.7
4.9
2.3
ug/l
1.09
18
29
57
191
3.66
14.58
2.8
2.4
0.6
0.8
e6/l
0.17
33
92
58
199
3.58
14.29
2.8
2.4
1.0
0.7
e6/l
0.23
34
99
70
309
2.84
10.99
1.6
2.0
1.7
0.8
mg/l
1.83
50
216
48
177
3.18
10.32
2.6
1.7
—
—
—
0
0
205
1582
4.33
10.28
20.8
7.8
97.1
95.8
ml/min/173m2
0.33
184
1274
28
74
4.18
9.84
5.4
2.3
1.2
1.2
mmol/l
0.25
28
67
14
23
6.42
8.28
2.1
4.3
3.8
3.8
e9/l
0.01
14
23
14
24
6.15
7.95
2.2
4.4
59.9
54.2
%
1.06
14
24
14
26
5.68
7.35
1.6
1.7
—
—
—
0
0
10
13
8.00
7.17
1.0
1.4
—
—
—
0
0
34
126
3.00
7.15
2.7
1.6
—
—
—
0
0
206
1698
3.52
7.13
23.0
9.1
22.0
23.4
mg/l
0.27
176
1262
12
20
6.28
6.98
1.1
1.5
—
—
—
0
0
14
28
5.27
6.80
1.6
1.6
—
—
—
0
0
31
114
2.99
6.60
4.0
2.4
—
—
—
0
0
33
129
2.83
6.30
2.7
1.6
—
—
—
0
0
23
78
3.17
5.60
1.3
1.3
—
—
—
0
0
215
1881
4.22
5.48
15.2
7.4
34.2
35.5
u/l
0.45
215
1833
93
621
1.85
4.69
2.9
2.5
0.0
0.0
estimate
0.00
24
107
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
7
5
14.38
4.60
1.0
1.4
—
—
—
0
0
22
82
2.87
4.57
2.7
1.4
—
—
—
0
0
34
158
2.36
4.56
3.1
2.1
25.3
26.1
%
0.12
29
142
14
39
3.76
4.56
2.1
1.8
—
—
—
0
0
9
12
7.76
4.39
1.0
1.3
—
—
—
0
0
92
625
1.80
4.30
4.4
3.5
0.0
0.0
estimate
0.00
25
114
18
64
2.97
4.06
1.7
1.5
—
—
—
0
0
7
7
10.27
4.04
2.6
1.1
186.1
181.7
u/l
—
7
7
8
12
6.86
3.70
1.0
1.3
—
—
—
0
0
8
12
6.86
3.70
1.0
1.3
—
—
—
0
0
8
12
6.86
3.70
1.0
1.3
—
—
—
0
0
20
83
2.55
3.41
5.4
12.4
95.7
93.5
%
1.70
20
83
89
633
1.67
3.36
3.0
2.5
0.0
0.0
estimate
0.00
21
99
19
83
2.41
2.93
5.6
12.3
0.6
0.7
%
1.11
19
83
19
84
2.38
2.86
5.3
12.2
1.4
1.8
%
0.58
19
84
11
36
3.16
2.85
2.3
1.8
—
—
—
0
0
23
111
2.19
2.84
8.6
14.5
119.3
133.1
g/l
1.63
23
106
8
18
4.57
2.82
1.1
1.1
—
—
—
0
0
217
2041
2.78
2.57
34.3
13.0
141.3
147.8
g/l
6.71
217
2014
70
500
1.58
2.48
2.8
2.5
—
—
—
0
0
89
677
1.52
2.36
3.4
2.8
1.2
1.4
ug/l
0.74
77
625
7
18
3.98
2.27
2.1
1.6
—
—
—
0
0
7
18
3.98
2.27
2.1
1.6
—
—
—
0
0
20
102
2.05
2.18
1.3
1.3
—
—
—
0
0
9
31
2.98
2.09
1.1
1.1
—
—
—
0
0
7
20
3.58
2.07
1.4
1.9
—
—
—
0
0
7
21
3.41
1.98
1.1
1.2
—
—
—
0
0
7
22
3.25
1.89
2.1
1.7
—
—
—
0
0
157
1739
0.68
1.85
4.2
3.8
2.9
2.9
mmol/l
0.19
149
1647
16
81
2.05
1.79
6.0
3.7
24.3
23.7
mmol/l
0.36
16
75
16
83
2.00
1.69
3.4
3.4
-0.7
1.9
mmol/l
1.65
11
52
157
1727
0.70
1.62
4.1
3.6
4.6
4.7
mmol/l
0.08
152
1639
43
302
1.52
1.61
3.1
2.7
0.1
0.0
estimate
0.41
24
107
157
1719
0.71
1.48
4.0
3.5
1.2
1.3
mmol/l
4.44
151
1632
9
38
2.42
1.47
1.2
1.6
—
—
—
0
0
5
16
3.17
1.44
1.2
1.6
—
—
—
0
0
9
40
2.30
1.42
1.2
1.2
—
94.0
—
0
8
62
480
1.40
1.41
3.7
2.8
41.5
65.6
ng/l
0.32
43
259
7
29
2.46
1.40
1.7
1.1
—
—
—
0
0
7
29
2.46
1.40
1.7
1.1
—
—
—
0
0
5
17
2.98
1.36
1.2
1.5
—
—
—
0
0
123
1068
1.33
1.33
3.9
3.4
10.8
7.7
mm/h
1.32
118
1001
6
24
2.54
1.31
1.3
1.1
—
—
—
0
0
10
49
2.09
1.24
1.0
1.2
—
—
—
0
0
37
268
1.46
1.21
4.0
3.2
657.1
1244.5
ng/l
0.44
28
184
35
251
1.47
1.20
2.3
2.8
609.2
1580.4
ng/l
0.79
28
189
152
1653
0.75
1.17
3.7
3.3
1.5
1.4
mmol/l
1.32
145
1573
64
516
1.34
1.12
3.2
2.7
24.5
24.1
%
0.03
18
146
11
60
1.88
1.04
8.5
3.2
60.8
57.1
%
0.17
11
60
5
22
2.30
1.04
1.0
1.2
—
—
—
0
0
10
53
1.93
1.03
1.3
1.0
—
—
—
0
0
10
53
1.93
1.03
1.3
1.0
—
—
—
0
0
55
450
1.29
0.87
2.2
1.6
92.4
95.5
pmol/l
0.18
36
236
8
133
0.59
0.76
1.0
1.8
—
—
—
0
0
15
100
1.54
0.75
1.3
1.2
—
—
—
0
0
187
1782
1.29
0.71
26.1
9.3
40.5
43.2
%
3.21
162
1510
5
27
1.87
0.69
1.0
1.0
—
—
—
0
0
7
44
1.61
0.65
2.9
2.7
—
—
—
0
0
46
382
1.26
0.65
1.7
2.5
—
—
—
0
0
117
1069
1.20
0.65
3.0
2.7
15.1
14.9
pmol/l
0.34
104
990
144
1534
0.83
0.64
3.6
3.3
6.0
5.9
mmol/l
0.24
136
1438
46
388
1.23
0.57
2.8
2.0
0.6
0.7
ug/l
0.35
28
186
137
1454
0.85
0.53
5.0
4.4
39.4
38.9
mmol/mol
0.19
131
1395
11
75
1.49
0.51
3.6
2.8
57.3
180.7
ng/l
1.30
11
65
44
380
1.20
0.45
2.0
1.6
1.7
1.7
mmol/l
0.01
38
334
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
1.4
3.4
—
—
—
0
0
9
71
1.28
0.36
12.8
15.9
23.6
24.1
mmol/l
—
9
66
23
269
0.84
0.29
1.6
1.7
—
—
—
0
0
39
348
1.15
0.28
1.7
2.4
—
—
—
0
0
37
412
0.88
0.26
1.2
1.2
0.5
1.0
u/ml
—
9
120
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
4.8
—
420.8
—
0
12
141
1368
1.08
0.20
3.6
3.3
1.7
2.7
mu/l
0.58
130
1280
23
203
1.15
0.20
1.4
1.7
406.1
429.7
pmol/l
0.26
18
181
7
61
1.15
0.17
2.1
1.7
—
—
—
0
0
148
1515
0.93
0.16
3.2
3.2
—
—
—
0
0
8
100
0.79
0.14
1.0
1.1
—
—
—
0
0
43
457
0.93
0.13
1.6
1.5
—
—
—
0
0
12
135
0.88
0.10
9.8
6.1
—
—
—
0
0
5
48
1.04
0.09
1.0
1.1
—
1.1
—
0
7
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
7
64
1.10
0.08
1.0
1.3
—
—
—
0
0
11
120
0.91
0.05
3.1
3.0
—
—
—
0
0
11
103
1.07
0.02
2.6
2.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
37.7
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
107.2
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
16.7
—
0
6
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.2
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
3.6
—
105.7
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
137.8
—
0
6
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_NONSEMINOMA_EXALLC – Non-seminoma of testis, excluding all cancers (controls excluding all cancers)
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).